[Antithrombotic therapy of ischemic heart disease].
D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy / Q000401:mortality; D010974:Platelet Aggregation / Q000187:drug effects; D011727:Pyridinolcarbamate / Q000627:therapeutic use*; D013300:Streptokinase / Q000627:therapeutic use; D013916:Thrombelastography; D013927:Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents; D011727:Pyridinolcarbamate; D006493:Heparin; D013300:Streptokinase
Antitromboticheskaia terapiia ishemicheskoĭ bolezni serdtsa